Literature DB >> 7946802

Renoprotective role of ACE inhibitors in diabetic nephropathy.

C E Mogensen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7946802      PMCID： PMC1025591          DOI： 10.1136/hrt.72.3_suppl.s38

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  68 in total

1.  Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.

Authors:  A Mimran; A Insua; J Ribstein; L Monnier; J Bringer; J Mirouze
Journal:  J Hypertens       Date:  1988-11       Impact factor: 4.844

2.  Slowing the progression of diabetic nephropathy.

Authors:  G Remuzzi; P Ruggenenti
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

Review 3.  ACE inhibitors and diabetic nephropathy.

Authors:  M E Molitch
Journal:  Diabetes Care       Date:  1994-07       Impact factor: 19.112

4.  Comparison of the renal effects of angiotensin converting enzyme inhibitor and calcium antagonist in hypertensive type 2 (non-insulin-dependent) diabetic patients with microalbuminuria: a randomised controlled trial.

Authors:  T Baba; S Murabayashi; K Takebe
Journal:  Diabetologia       Date:  1989-01       Impact factor: 10.122

5.  Captopril and atenolol are equally effective in retarding progression of diabetic nephropathy. Results of a 2-year prospective, randomized study.

Authors:  L D Elving; J F Wetzels; H J van Lier; E de Nobel; J H Berden
Journal:  Diabetologia       Date:  1994-06       Impact factor: 10.122

6.  Placebo-controlled trial of lisinopril in normotensive diabetic patients with incipient nephropathy.

Authors:  M J O'Donnell; B R Rowe; N Lawson; A Horton; O H Gyde; A H Barnett
Journal:  J Hum Hypertens       Date:  1993-08       Impact factor: 3.012

7.  The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

Authors:  E J Lewis; L G Hunsicker; R P Bain; R D Rohde
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

8.  Comparison of the effects of an angiotensin converting enzyme inhibitor and a calcium antagonist in hypertensive, macroproteinuric diabetic patients: a randomised double-blind study.

Authors:  M J O'Donnell; B R Rowe; N Lawson; A Horton; O H Gyde; A H Barnett
Journal:  J Hum Hypertens       Date:  1993-08       Impact factor: 3.012

9.  Short term effect of captopril on microalbuminuria induced by exercise in normotensive diabetics.

Authors:  G Romanelli; A Giustina; A Cimino; U Valentini; E Agabiti-Rosei; G Muiesan; G Giustina
Journal:  BMJ       Date:  1989-02-04

Review 10.  Management of renal disease and hypertension in insulin-dependent diabetes, with an emphasis on early nephropathy.

Authors:  C E Mogensen
Journal:  Curr Opin Nephrol Hypertens       Date:  1992-10       Impact factor: 2.894
View more
  3 in total

Review 1.  Lisinopril. A review of its pharmacology and use in the management of the complications of diabetes mellitus.

Authors:  K L Goa; M Haria; M I Wilde
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

2.  What are the most effective interventions in preventing diabetic foot ulcers?

Authors:  Lawrence A Lavery; Edgar J G Peters; David G Armstrong
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

3.  An encounter with enalapril-induced resistant, life-threatening angioedema at rural health center in Botswana.

Authors:  Nikhil Anish; Abiy Mulugeta Gabremedhin
Journal:  Indian J Crit Care Med       Date:  2016-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.